throbber
1\) ~ '1'1 ~
`~. "3d..ip
`v~ - (Q lt I
`C -~
`
`RESEf-?VE COPY
`
`RETlJRr~ TO
`C I R C U L 1\ T I 0 IJ D ESt(
`
`PFIZER EX. 1100
`Page 1
`
`

`

`nature
`
`26 March 1987
`Volume 326
`Issue no. 6111
`
`Crystals of a complex of antibody
`Fab fragment and influenza virus
`neuraminidase. Photogra ph by
`Julie Macklin and Stewart Butter(cid:173)
`worth in backlighting to illumin(cid:173)
`ate different crystal face ts in
`diffe rent colours. See p.358 and
`News and Views p.334.
`
`• Plastic magnets?
`... pages 335 and 370
`Organic polymers can be fer(cid:173)
`romagnetic, a property hither(cid:173)
`to .known only in inorganic
`materials.
`• Electro-detection in
`duck-billed platypus
`... page386
`
`Electroreceptors in the bill of
`the duck-billed platypus can
`pick up muscular electrical
`activity fro m the tail flick of
`freshwater shrimp on
`the
`which it feeds.
`• Snow goose probes
`... page392
`Detection of multiple mater(cid:173)
`nity and paternity in single
`broods of lesser snow geese
`pioneers the use of polymor(cid:173)
`phic DNA analysis to study
`ecology and population gene(cid:173)
`tics.
`• Nerve growth factor
`... page353
`Sensory neurons innervating
`developing skin do not synthe(cid:173)
`size nerve growth facto r until
`their fibres reach their cuta(cid:173)
`neous targets.
`• 3D protein structure
`... page347
`Techniques fo r predicting the
`tertiary structure of proteins
`may lead to the design of novel
`molecules .
`
`NEWS
`317 Towards the next trade war?
`318 US-French AIDS accord • Plutonium dispute in Ger(cid:173)
`many
`319 US fights to protect semiconductor industry • Japan
`fights to protect telecommunications
`320 US Air Force overhauls ASAT programme •
`321 Europe acts on ozone layer • Another crisis for SERC
`322 Eye institute proposed • Japanese X-ray satellite •
`AIDS institute for India?
`323 India studies herbal remedies • Japan plans to sequ(cid:173)
`ence humane genome
`324 Physicists brood at Trieste
`325 More links urged with Chinese industry • Doubts on
`Soviet dam
`CORRESPONDENCE
`326 Hazards of genetic engineering • Megafauna versus
`megafauna • Chinese universities
`NEWS AND VIEWS
`327 New ways with matter/antimatter
`328 A quiet supernova? David Lindley • Fluctuations in a
`patchy world John H Lawton
`329 Single-atom masers and the quantum nature of light
`Peter Knight
`330 Tumour necrosis factor: Polypetide mediator net(cid:173)
`work Lloyd J Old
`331 Mass extinctions: iridium anomalous no longer?
`Stephen K Donovan
`332 Eukaryotes with no mitochondria T Cavalier-Smith
`334 Antibody-antigen
`flexibility Robert Huber &
`William S Bennett
`335 Organic ferromagnets: Polymers from the Soviet
`Union Richard Friend
`336 Developmental neurobiology: Trophic factor theory
`matures J W Lichtman & PH Taghert
`SCIENTIFIC CORRESPONDENCE
`337 Nomenclature of immunological markers C Milstein
`• Soliton theory and Jupiter's great red spot P L Read
`338 Glycine-binding sites and NMDA receptors in brain
`N G Bowery • Can a negative quantity be deemed a proba(cid:173)
`bility? P T Landsberg
`BOOK REVIEWS
`339 The Shaping of Modern Psychology by L S Hearnshaw
`Alan Costall
`340 Helium Cryogenics by S W Van SciverP V E McClintock
`• The Sickled Cell by S J Edelstein D R Higgs
`341 On the heart beat -
`two books on cardiac muscle
`Andrew P Somlyo
`342 The Forms of Color by K Gerstner J D Mallon
`COMMENTARY
`343 The sombre view of AIDS M Rees
`346 Science meets Islam in the Saudi desert P Newmark
`Contents continued ..,..
`
`THIS WEEK
`• Sombre view of AIDS
`... page343
`A worst-case study shows a
`surprisingly high fraction of
`those infected wi th the AIDS
`vi rus may go on to develop the
`fu ll disease.
`... page319
`Meanwhile, a deal between
`the French and US sides in the
`AIDS patents dispute will give
`a boost to AIDS research by
`fu nding a new resea rch centre.
`
`Population stability
`.. pages 328 and 388
`The belief that greater com(cid:173)
`plexity leads to greater ecolo(cid:173)
`gical stability is challenged by
`the observation that spatial
`heterogeneity destabilizes the
`in teractions between aphids
`and predatory ladybirds.
`
`Living fossils
`.. pages 332 and 411
`The microsporidia, a group of
`microbial parasites, may be
`living relics of the ea rliest
`phases of eukaryotic evolution.
`
`F ASEB showcase
`. page419
`
`Product Review leads with the
`increasingly popular technique
`of high-speed countercurrent
`chromatography.
`
`PFIZER EX. 1100
`Page 2
`
`

`

`~35~8------------------------------------------ARTICLES-----------------------N~A~TU~R=E_v~o~L~-~32~6~2~6~M~A~R~C~H~I~98~7
`
`13. Stoeckel, K., Schwab, M. & Thoenen, H. Brain Res. 89, 1- 14 ( 1974 ).
`14. Angeletti, R. H. & Bradshaw, R. A. Proc. natn. Acad. Sri. U.S.A. 68, 24 17-2420 ( 197 1).
`15. Scott, J. era/. Nature 302,538-540 ( 1983).
`16. Ullrich, A., Gray, A., Berman, C. & Dull, T. J. Nature 303, 82 1- 825 (1983).
`17. Darling, T. L. J. era/. Cold Spring Harb. Symp. quant. Bioi. 48, 427-434 (1983).
`18. Menescini-Chen, M.G., Chen, J. S. & Levi- Montalcini, R. Archs ita/. Bioi. 116, 53- 84 (1978).
`19. Letourn eau, P. C. Devl Bioi. 66, 183-196 (1978).
`20. Gundersen, R. w_. & Barrell, J. N . Science 206, 1079- 1080 ( 1979).
`21. Levi-Montalcini, R. Prag. Brain Res. 45, 235-258 (1976).
`22 . Jl.enehan, W. E. & Munger, B. L. J. camp. Neur~/. 246, 129- 145 (1986).
`23 . lggo, A. Br. med. Bull. 33,97- 102 ( 1977 ).
`·,
`
`24. lggo, A. & Andres, K. H. A Rev. Neurosci. S, 1-3 1 ( 1982).
`25. Davies, A. M. & Lumsden, A. G. S. J. camp. N eural. 223, 124- 137 ( 1984).
`26. Davies, A. M. & Lumsden, A. G. S. J. camp. Neural. 253, 13- 24 ( 1986).
`27. Korsching, S. & Thoenen, H. Proc. natn. Acad. Sci. U.S.A. 80,35 13- 3516 ( 1983).
`28. Bandtlow. C., Heumann, R., Schwab, M. & Thoenen, H. EMBO J. (i n the press).
`29. Rush , R. A. Nature 312, 364-367 (1984).
`30. Finn, P. J., Ferguson, I. A., Renton, F. J. & Rush, R. A. J. Neuracytol. IS, 169- 176 (1986).
`31. Lumsden, A. G. S. & Davies, A. M. Natu" 306, 786-788 ( 1983 ).
`32. Lumsden. A. G. S. & Davies, A. M. Natu" 323, 538- 539 ( 19861 .
`33. Lowry, 0. H., Rosenbrough, N.J., Farr, A. L. & Ranqall , R. J. J. bioi. Chern. 193, 265-275
`(1951 ).
`
`Three-dimensional structure of a complex of
`antibody witb influenza virus neuraminidase
`P. M. Colman, W. G. Laver·, J. N. Varghese, A. T. Baker, P. A. Tulloch,
`G. M. Airt & R~ G. Webster:t:
`CSIRO Division of Protein Chemistry, 343 Royal Parade, Parkville, 3052, Australia
`*John Curtin School of Medical Research, Australij!n National University, Canberra 2601 , Australia
`t Department of Microbiology, University of Alabama, Birmingham, Alabama 35294, USA
`* St Jude Children's Research Hqspital, Memphis, Tennessee 38101, USA
`
`The structure of a complex between influenza virus neuraminidase and an antibody displays features inconsistent with th e
`inflexible 'lock and key' model of antigen-antibody binding. The structure of the antigen changes on binding, and that of
`.
`the antibody may also change; the int£!raction therefore has some of the character of a handshake.
`
`WE report here the first analysis by X-ray diffraction of the
`three-dimensional structure 'or a viral antigen complexed with
`an antibody. Fab fragment. The antigen is the influenza virus
`enzyme neuraminidase (reviewed in ref. 1).
`Sufficiept data on the chemical 2 and spatial 3
`6 structure of
`-
`antibodies emerged in the 1970s to provide a pasis for under(cid:173)
`standing how variation in antibody structure occurs, but the
`question of how different antibodies aq:ommodate different
`macromolecular epitopes remains unresolved . The antigen bind(cid:173)
`ing fragments (Fab) of immunoglobulins t;:onsist of a light chain
`(L) and the N-terminal half of the heavy (H) chain. On each
`chain there are two globular domains of -1 OQ amino acids, the
`N-terminal domain ill each chain being variable (VL and VH)
`and the C-terminal domain conserved (CL and CH1) in their
`amino-acid sequences. VL and VH domains are associated with
`each other, forming a variable module and CL and CH 1
`for111 the constant module. Three complementarity-determin(cid:173)
`ing ' re1gions (CDR1, 2 and 3) from each of the VL and VH
`domains are clustered at the extremity of the Fab arms, and
`
`they determine the binding specificity of an immunoglobuli n
`molecule.
`11
`The three-dimensional structures of five free Fab fragments 7
`-
`and one in complex with lysozymet 2 have been reported. Four
`of the structures, New7
`, Kol 8
`, McPC6039 and 1539 10
`, are well
`refined and form the basis of the following generalizations which
`also appear valid for the other two, S10/ 1 (ref. 11 ) and 0 1.3
`(ref. 12). The pairing of VL and VH domains is determined by
`amino acids from· bpth the framework region and the CDRs.
`Most of the surface area buried in the interface derives fro m
`conserved residues and this observation explains the largely
`conserved geometry of VL-VH pairingD. Small differences in
`pairing presumably result from interactions among the CDR
`amino acids 14
`. Analysis of the VL-VH contact surface shows it
`to be unlike other interfaces between ,8-sheets 15
`. Amino aci ds
`from the outermost strands of the two sheets fold into the
`interface where they contribute the bulk of the buried surface.
`CL -CH 1 dimers are similarly conserved in their association
`pattern 16. More variable is
`the so-called elbow anglet ?.ts
`
`h
`
`Fig. I Schematic diagrams of chain fold in N2 and
`N9 neuraminidase viewed down the 4-fold axis (a)
`and perpendicular to thi s axis (b). The symmetry axis
`is bottom right in a arid stan ding vertical at the left
`rear in b. The view of the neuraminidase in b is similar
`to that shown in Fig. 5. Tagged residues and adjacent
`chain segments are referred to in the text. N2 number(cid:173)
`ing is used. In a, the side chains of amino acids 368; 370
`point towards the viewer, whilst that of Arg 371 points
`away and into the catalytic site located above and to
`the right of co· 371. Mutations at positions 367, 369,
`370, 400, and 432, as detailed in Fig. 2, abolish the
`binding of NC41 antibody to neuraminidase, whereas
`mutations at 368 and 329 reduce that binding. A muta(cid:173)
`tion at 220, which falls outside the NC41 epitope, has
`no effect on NC41 binding to neuraminidase (see Fig.
`2). In a, solid chain segments show regions in contact
`with the N C~ l antibody; contact assignments in the
`broken solid segments are ten!ative.
`
`PFIZER EX. 1100
`Page 3
`
`

`

`l "'"" 'OL " ' " MmH ""'
`
`------ARTICLES~---------------~359
`
`100~~._~~----~------~
`
`90
`
`80
`
`?{!.
`
`1
`
`\
`.,
`
`I
`I
`I
`I
`
`1/ 100 1/ 200
`1/ .-00
`NC 41 lgG d il u ti on
`
`1/800
`
`Fig. 2 Neuraminidase inhibition ( NI ) curves of monoclon al anti(cid:173)
`body NC41 act ing on N9 neura minidase (NA) and a number of
`variants selected with different monoclonal antibodies to N9
`neuraminidase. Assays used fetuin as a substrate, as described 58
`The amino-acid sequence changes of the variants a re : •. 434 ( 432
`in N2 numbering) K-+N; 400 (400) N-+K; 371 (370) S -+ L; 370
`(369) A-+ D; 368 (367 ) S-+ N; 0 , 369 (368) I .... R; 6 , 331 (329)
`N-+ D (design ated as OX2 in text ); 0 , 222 (220) R -+ Q (this curve
`is identical to wild-type). The a mino-acid sequence changes were
`determined by sequencing e DNA of the vi ral RNA stra nd encoding
`the neuraminidase as described 59
`. The changes a re shown on the
`3-D structure of the mondmer in Fig. I.
`
`describing the angle between the local axes of symmetry in the
`V and C modules.
`The identification of antigenic regions on protein molecules 19
`has been aqempted by a variety of method~ 20- 23 but the structural
`basis of antigenicity remains unclear. Current models of antigen(cid:173)
`antibody association are based on classical ideas of lock and
`ke y complementarity. But it has been suggested24 that the anti(cid:173)
`genic regions of proteins are located in the more flexible chain
`segments, which may adopt a configuration that allows antibody
`binding. It is not known whether binding to antigen has any
`effect on the structure of an antibod/ 5
`, nor whether, if such an
`effect exists, it has biological significance. For the Fab-lysozyme
`complex 12, the parts of the lysozyme that make contact with the
`an tibody are not the more flexible regions of free lysozyme. No
`de formation of the antigen nor any structural change in the Fab
`was observed 12.
`The antigen in this study is the neuraminidase of influenza
`virus. It is a tetramer of subunits with relative molecular mass
`
`I 60,000 (M, 60 K) with circular symmetry, and is attached by a
`stalk to the viral membrane . Neuraminidase 'heads' can be
`( liberated from the virus by proteolysis26
`• There is a ntigenic
`/ variation in the heuraminidase between different strains of virus .
`l Antibodies against neuraminidase do not neutralise virus infec-
`tivity, but do modify the disease in favour of the host27
`• The
`three-dimensional structures of neuraminidase heads of sub(cid:173)
`types28 N2 (refs 29, 30) and N9 (A.T.B. , J.N .V., W.G.L., G. M.A.
`and P.M.C., manuscript in preparation ) are known and a sche(cid:173)
`matic of the chain fold is shown in Fig. I. Neuramirtidase of
`subtype N9 from a·n avian influenza virus, G70c31, has been
`used in this study. Its structure is very similar to the N2 enzyme
`as expected from the sequence homology of 50% (ref. 32).
`We previously reported electron and low resolution X-ray
`diff raction studies of Fab-neuraminidase complexes 33 and, more
`
`recently, the crystallization of another complex (with NC41 Fab)
`which diffracts X-rays to beyond 3 A resolution34. The NC41
`antibody cari suppress the yield of virus from infected cells and
`therefore
`allows
`the
`selection of antigenic variants.
`Neuraminidase-inhibition curves (Fig. 2)
`.show that some
`variants with single sequence changes .are not inhibited at all
`by NC41 antibody whereas others are partially inhibited. The
`location of these sequence changes on the three-dimensional
`structure of neuraminidase is shown in Fig. 1.
`Protomer structure
`Electron microscopy of negatively stained protomers of complex
`show tetrameric neuraminidase heads with four Fab fragments
`atta_ched (data not shown). Their image appearance is very
`stmtlar to that of protomers of N9 neuraminidase complexed
`with the Fab fragments of antibodies 32/ 3 and NC35 (ref. 33)
`and may be described as a square box (IOOx 100 x60 A) with
`four antennae ( Fab molecules) attached to one surface on the
`outer corners. The overall shape of the proto mer from the X-ray
`diffraction study (Fig. 3) is consistent with the electron micro(cid:173)
`scope images. the Fab arms subtend an angle of 45° to the
`plane of the tetrameric neuraminidase head, slightly foreshor(cid:173)
`tened in the electron microscope image33
`.
`Surface loops of the neuraminidase in contact with the CDRs
`are 368-370, 400-403 , 430-434 and parts of 325-350. Of these,
`the conformation of the 325-350 loop is still tentative. It was
`the most difficult region of the original N2 neuraminidase struc(cid:173)
`ture29
`to
`interpret and
`remains ambiguous
`in
`the N9
`neuraminidase structure (A.T.B. et a/., manuscript in prepar(cid:173)
`ation). Such instances of ill-defined structure are typical of
`surface loops of polypeptides subject to thermal motion or
`statistical di so rder.
`Early indications on the distribution of temperature factors
`in the uncomplexed N2 neuraminidase, based on crystallo(cid:173)
`graphic refinement of that structure at 2.2 A resolution and an
`R-factor of 0.293, show above-average thermal parameters in
`chain segments 109- 111, 141-142, 221-222, 243-247, 305-309,
`316-319, 327-331, 338-343,365-369, 399-402, 429-437 and 461-
`469 (J.N.V. and P.M.C., unpublished data) . Elevated B values
`around residue 330 may correlate with inaccurate modelling as
`discussed above. All the segments listed here are surface loops.
`Note that only one of the hotter loops is underneath the
`neuraminidase head . We emphasize that the temperature factor
`analysis is preliminary, and indeed relates to N2, not N9,
`neuraminidase.
`The monoclonal variant of N9 neuraminidase known as OX2
`(As n 329-> Asp 329, N2 numbering) crystallizes iso morphously
`with wild-type N9-NC41 Fab complex34. NC41 inhibits the
`OX2 neuraminidase va riant less than it does wild-type (Fig. 2).
`Refinement of the N9- NC41 Fab structure using data collected
`from the OX2-NC41 Fab complex yields an R~ factor of 0.36
`for a model with tight geometry. This result is comparable with
`the current R-factor agai nst the native dataset and confirms our
`earlier conclusion 34 that the binding of NC41 Fab to wild-type
`and OX2 N9 neuraminidases is isosteric. Either some bonding
`'glue' is absent or repulsive forces have been introduced by the
`mutation (Fig. 2), but there is no detectable rearrangement of
`the antibody on the antigen at this stage. The precise lo.cation
`of residue 329 (N2 numbering) in the N2 and N9 structures is
`unclear. Refinement of the OX2-NC41 Fab structure should
`eventually reveal the structural basis for the reduced binding of
`NC41 to OX2 compared with wild-type N9.
`The third CDRs on both heavy and light chains are not yet
`completely modelled, and the conformation of the 325-350
`region on the antigen remains uncertain, so we cannot identify
`the amino acids that interact in the interface. All the CDRs,
`with the possible exception of light-chain CDRI appear to ma ke
`contact with the epitope. A preliminary assessment is that there
`are no more contacting residues than the 16 or 17 observed in
`the Fab-lysozyme structure12.
`
`PFIZER EX. 1100
`Page 4
`
`

`

`M603
`4.2 (0.7)
`
`12.4 (2.4)
`2.1 (0.7)
`
`KOL
`6.5 (0.4)
`5.0 (0.3 )
`
`10.8 (2. 1)
`
`NC41
`12.2 ( 1.0)
`8.8 (1.3)
`12.1 (0.7)
`
`Comparison of four different Fab quaternary structures. Upper right
`triangle: VL domain of the row Fab was mapped into the VL domain
`of the column Fab using the c. coordinates of residues 33-39, 43-47,
`84-90, 98- 104 (Kabat2 numbering). These amino acids were chosen
`because they define the interface between VL and VH domains". The
`calculated transformation was applied to the V H domain of the row Fab
`and the additional rotation in degrees (and translation in A) to optimize
`overlap of the two VH domains in question was calculated and is given
`above. c. coordinates used for overlap of VH domains were 34-40,
`44- 48,88-94 and 103- 109. Lower left triangle: CL domain of the column
`Fab was mapped into the CL domain of the row Fab using the c.
`coordinates of residues 118-124, 131- 137, 160- 162 and 174- 178 (Kabat 2
`numbering). These amino acids were chosen because they define the
`interface between CL and CH, domains16. The calculated transformation
`was applied to the CH 1 domain of the column Fab and the additional
`rotation in degrees (and translation in A) to optimize overlap of the
`two CH, domains are shown. c. coordinates used for overlap of CH ,
`domains were -121 - 125, 139- 145, 172- 179 and 186-190. Amino acid>
`from the interface were used because if this set is expanded to include
`other pans of the domain structure, the correlation between small
`rotation angles and similar chain classes that is observed for the C
`module is less good. The largest r.m.s. distance between domain structu re
`alignments is 0. 7 A. A similar comparison was done for the V modules
`of the M603 (antiphosphocholine) and uncomplexed SI0/ 1 (antine(cid:173)
`uraminidase) Fab fragments. No measurable difference in the way the
`V L and V H domains associate in those antibodies was detected. A
`comparison elsewhere of Kol and New V modules8 yields a value of
`9•. The value reponed here (6.5•) is smaller because it is uninfluenced
`by structural differences outside of the interface zone.
`
`Table I Quaternary structure comparisons of Fabs
`
`NEW
`M603
`KOL
`NC41
`
`NEW
`
`12.7 (2.3)
`2.5 (0.0)
`11.5 (0.4)
`
`~~~---------------------------------------ARfiCL£$,--------------------~N~A~TU~R~E ~v~o=L.~3~26~2~6~M~AR~C~H~t~98~7
`Quaternary structure of the Fab
`The amino-acid sequence of the Fab is known (G.M.A., unpub(cid:173)
`lished data). The assignment of heavy and light chains in the
`Fab structure
`is consistent with side-chain densities at
`homologous positions on the two chains, such as heavy-chain
`( H) Trp 47 and light-chain (L) Leu 46, H Val 37 and L Tyr 36,
`and, H Trp 103 and L Phe 98. Heavy-atom binding sites also
`show an asymmetry which is consistent with these observations.
`The quaternary structures of known Fab fragments were com(cid:173)
`pared as described in Table 1. The lower left triangle of entries
`indicates that CL -CH, pairing is a function of immunoglobulin
`chain subtype since -y1: A chains (as in Kol and New) show a
`consistent mode of association as do a or -y2. : K chains (as in
`M603 and NC41). Small but significant alterations in Y-domain
`pairing are observed between Kol, New and M603 (Table I,
`upper right). This variation in VL-VH association has been
`attributed to the fact that_ the CDRs contribute partially to the
`dimer interface between the two domains in the Y-module14,
`although in the case of Kol we suggest that intimate crystal
`contacts involving the CDRs may contribute.
`Comparison of these three Fabs with NC41 complexed with
`neuraminidase shows, in each case, a significantly larger
`difference in V L-V H association. Compared with Kol, the dis(cid:173)
`tance between H CDR2 and L CDR3 is larger and the relative
`positions of the CDRs around the antigen-binding surface are
`altered by up to 4 A. A movement of this magnitude is of the
`order of the distance between adjacent a-carbon atoms on a
`polypeptide and may be considered as dramatic as a sequence
`insertion or deletion in a structurally critical part of the molecule.
`As well as the bulk movi:ment of domains described here, the
`CDR loops may be flexible and able to adapt further to an
`epitope.
`Building an atomic model into tlie penultimate electron
`density map (that in which no phase information from the Fab
`structure had been included) required the rotation of H Trp 47
`180° around C 0 -C13 compared with its position in Kol. M603
`and New are the same as Kol at this point. The positions of the
`loops at residue 40 on both heavy and light chains also required
`remodelling. Therefore the reorganization of the interface
`through sliding of domains has consequences for the domain
`structure of the VL and VH.
`The sequence of the NC41 VL and VH domains shows that
`those framework amino acids on both the light chain (Tyr 36,
`Gin 38, Pro 44, Tyr 87, Phe 98) and the heavy chain (Val 37,
`Gin 39, Leu 45, Trp 47, Phe 91, Ala 93, Trp 103) that are buried
`in the interface15 are conserved as expected. There is nothing
`in the primary sequences of the CDRs of NC41 to suggest a
`cause of the unusual domain association. An independent analy(cid:173)
`sis of the N C41 sequence confirms this view (C. Chothia, per(cid:173)
`sonal communication).
`Two other Fab structures are known to fit the normal pattern
`of VL-VH association, the free antineuraminidase monoclonal
`antibody SI0/ 1 (ref. II ) and the complexed anti-lysozyme
`monoclonal antibody D1.3 (ref. 12). Among light-chain dimers
`the picture is less clear. Although several examples ofYL- Ywlike
`association have been observed3·35"37
`, there are two clear excep(cid:173)
`tions38-39, one of which is said to be caused by the CDR residue
`L 91, or, in our view, perhaps by a His at residue 38.
`If changes in the amino-acid sequence of the CDRs (which
`are only a small part of the interface) can modulate the pairing
`pattern, binding of the six CDRs to a macromolecula r surface
`might similarly perturb the V L-V H interface. Without knowing
`the three-dimensional structure of the free NC41 Fab we cannot
`definitely conclude that the antibody structure has changed on
`binding antigen, but we believe that this explanation is more
`plausible than the alternative, which requires that special
`sequences in the C DRs alone have determined the pairing
`pattern.
`Other data support conformational changes in antibodies
`when antigen or hapten bihds40"44. Changes in circular dichro-
`
`ism40 or circular polarization of Huorescence42 indicate an
`altered environment for aromatic residues after antigen bi nds
`to antibody, and kinetic data support a bi-molecular process
`with distinct conformational states for bound and free Fab41·43•44
`•
`Both of these aspects are embodied in the sliding V L-VH model
`presented here.
`Direct structural evidence has been presented for hapten(cid:173)
`•46. In that
`induced structural changes in a Bence- Jones protein45
`case hydrophobic ligands can apparently penetrate the V L-V L
`interface and signal their presence to• the C-module. Strain
`introduced in the structure of the C-module can be relaxed by
`reducing and re-oxidizing the disulphide bond between the
`C-terminal regions of the two light chains46. Table I indicates
`that in the neuraminidase- NC41 complex no significant changes
`in the quaternary structure of the C-module have occurred .
`Analysis of the pseudo-symmetry axes of theY and C modules
`shows that the angle between these a xes, the elbow angle, is
`- 150°, which is intermediate in the observed range of 130- 180°
`for other Fab structures. The sense of the bending is the same
`as in all other Fab fragments, with VH and CH, domains closer
`together than the VL and CL domains.
`Conformational changes in the antigen
`The neuraminidase upper surface loop involving residues 367-
`371 was remodelled to better fit the density as observed in the
`complex. Adjacent parts of the loop which were also omitted
`from the phasing process (residues 364- 366 and 372- 373) fit the
`density as if they are rigidly attached to the N9 core. The C~
`atoms of residues 368-371 have been moved by I A or more
`from their position in N9 neuraminidase (Fig. 4). Least-squares
`refinement of the structure to R = 0.35, gave a mean shift of
`0.4 A in all C., atoms with a standard deviation of 0.2 A. The
`current position of the 370 loop (Fig. 4) shows displacements
`of more than 1.2 A for c. atoms 369- 371 compared wit h their
`
`PFIZER EX. 1100
`Page 5
`
`

`

`'·~~T~U~R~~~·~vo~L~-~3~26~26~M~A~R~C~H~t~98~7------------------------ARTICL£S--------------------------------------------~~~t
`fig. 3 Stereo images of the c. skeleton of the
`protomer, showing four Fab molecules attached
`tetrameric neuraminidase
`'head'.
`to one
`Neuraminidase, purple; heavy chain, green;
`light chain, blue. View with the protomer 4-fold
`axis vertical, but tipped towards the viewer. The
`crystals of N9- NC41 Fab belong to the space
`group P42 12 with a= 167 A, c = 124 A (ref. 34).
`There is one quarter of a protomer per asym(cid:173)
`metric unit and 70% of the cell volume is
`occupied by solvent. Data were collected photo(cid:173)
`graphically to 3 A resolution. In all, 67,976
`measurements of 25,241 independent reflections, representing 76% of the data in the 3 A sphere, were merged with an R-factor on intensities
`of 0.12. Phasing was initiated through two heavy atom derivatives (potassium tetra-chloro-platinate and diamino-dinitro-platinum). An envelope
`was computed60 on the basis of a 5 A resolution electron-density map allowing the location of the neuraminidase tetramer on the crystallographic
`4-fold axis to be determined first by inspection and subsequently by correlation methods in real space and rigid body least-squares refinement61
`,
`resulting in a correlation coefficient of 0.204 between Fo bs and Fcak for data in the range 5-3.5 A. It was now clear which surface regions of
`the neuraminidase were in contact with the remaining electron density in the image, and, in subsequent use of neuraminidase as partial
`structure in the phasing process, those regions were excised. A second electron density map, now at 3.5 A resolution, was phased on the two
`derivatives (one to 5 A and one to 3.5 A), the neuraminidase partial structure, and solvent flattening from a redetermined envelope. The four
`domains of the Fab fragment were recognised in this map and fitted independently by real-space correlation methods with the known Fab
`structure Kol8. Rigid-body least-squares refinement with five groups, neuraminidase, VH, CH., VL and CL produced shifts of up to IS in
`group orientations and led to an R-factor of 0.425 and a correlation coefficient of 0.308 for data between 5 and 4 A resolution. The structure
`is based on a 3 A electron density map, which is phased in addition to the information listed above with the structure of the Fab fragment
`excluding the complementarity-determining loops. Thus there is no structural prejudice in the image of those parts of the antigen or antibody
`that are near, or in, the bonding interrace. Further refinement62 has since reduced the residual to 0.35 for data between 6 and 3 A resolution.
`The r.m.s. error in the atomic positions is of the order of 0.5 A at this stage.
`
`Fig. 4 Stereo image of the electron density
`map (2Fo- Fc, R = 0.35) of the neuraminidase
`loop 368-372 in the complex with NC41 Fab.
`Residues here are labelled 868-872. The yellow
`model shows the c11rrent fit of the loop in the
`complex structure. The purple model is the
`position of this loop in uncomplexed N9
`neuraminidase.
`
`Fig. 5 Stereo image of one quarter
`of the protomer, showing the Fab
`bound to the side of the active site
`cavity on the enzyme. The enzyme
`active centre is facing the viewer,
`below and to the left of the antibody
`binding site, and is coloured yellow.
`The neuraminidase perspective is as
`in Fig. 1 b. Neuraminidase, green;
`heavy chain, purple; light chain,
`blue.
`
`PFIZER EX. 1100
`Page 6
`
`

`

`~~~2------------------------------------------ARTICLES----------------------~N~A~TU~R~E_v~o~L~-~32~6~2~6~M~A~R~C~H~1~98~7
`
`position in free N9 neuraminidase. Thus the antigen is distorted
`by interaction with the antibody.
`inhibit
`Most monoclonal anti-neuraminidase antibodies
`neuraminidase activity against fetuin, but only some of these
`also inhibit activity against the trisaccharide sialyl-lactose47.
`Although NC41 Fab cannot sterically block entry of a trisac(cid:173)
`charide into the active site (Fig. 5), NC41 does inhibit this
`activity (R.G.W., manuscript in preparation). We suggest that
`one possible mechanism for enzyme inactivation is the small
`displacement of Arg 371, which points directly into the catalytic
`site. We cannot yet rule out other interpretations, such as the
`effect of the antibody on steering substrates and products into
`or out of the active site. It has been shown that changing Arg 371
`for Lys by site-specific mutagenesis results in the loss of90-95%
`of enzyme activity, although the mutated protein is correctly
`folded (M. R. Lentz, R.G.W. and G.M.A., manuscript in prepar(cid:173)
`ation).
`Deformation of antigens by antibodies has been proposed to
`explain a variety of experimental data, including single-hit
`kinetics for neutralization of polio virus48 and altered binding
`affinity for second antibodies binding noncompetitively to the
`antigen49
`• The capacity of anti-apomyoglobin antibodies to,
`effectively, expel the haem from myoglobin has long been
`known50. There are also many reports of antibodies inhibiting
`enzymes51 . Our results directly demonstrate that conformational
`changes can be induced in antigens by antibodies. Furthermore,
`the change observed here, although small, correlates with the
`inactivation of the neuraminidase towards sialyl-lactose. Other
`anti-neuraminidase antibodies
`that
`inhibit neuraminidase
`activity only towards large substrates and, like NC41, can select
`antigenic variants, probably inhibit enzyme activity by blocking
`access of large substrates to the active site. We are testing the
`hypothesis that such antibodies do not distort the active site of
`the enzyme by an X-ray diffraction study of the N9-NC10 Fab
`complex34
`• Unlike NC41, this antibody does not inhibit enzyme
`activity on sialyl-lactose. Antigen distortion is likely to be but
`one of a number of possible mechanisms for virus neutraliz(cid:173)
`ation52.
`
`Conclusions
`The structure of a complex between an antibody and influenza
`virus neuraminidase shows features inconsistent with a rigid
`'lock and key' model for antibody-antigen interactions. In con(cid:173)
`trast to the findings from a lysozyme-antibody complex12 we
`observe ( 1) an unusual V L-V H pairing in the V module of the
`Fab, and (2) local perturbation of the antigen at the centre of
`the epitope. The interaction therefore has some of the character
`of a handshake. NC41 Fab has not yet been crystallized, and
`we can only suppose on the basis of sequence data that its
`structur

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket